Metabolic Chemistry Panel To Test Risk Factors For Metabolic Syndrome

Armen Hareyan's picture

Metabolic Syndrome

Polymer Technology Systems announced they have a new test strip available; the Metabolic Chemistry Panel, to check three of the main indicators for metabolic syndrome -- triglycerides, glucose, and HDL Cholesterol.

The panel is run on a CardioChek PA Point-of-Care analyzer for use by physicians, pharmacists, and other healthcare professionals. The test strip recently received FDA 510(k) clearance, and is CLIA-waived. It takes approximately two minutes to run, and uses a fingerstick sample of whole blood.

In the U.S., it is estimated that 20% of adults (47 million) have metabolic syndrome, with incidence approaching 50% in the elderly. Understanding metabolic syndrome and making lifestyle adjustments can reduce the risk of coronary artery disease, a leading cause of death in the United States. Weight control, specifically reduction of the waist measurement, lowering blood pressure, and reducing high cholesterol and glucose levels are important ways to reduce risk factors for heart attack, stroke, and diabetes.


"Our Metabolic Chemistry Panel is an important breakthrough in helping physicians identify patients who may be at risk for Coronary Artery Disease, stroke or diabetes," says PTS President Robert Huffstodt. "This new test panel alerts and enables healthcare professionals to provide early intervention, which can lead to reduced healthcare costs in the long run."

CardioChek systems are hand-held analyzers used with PTS Panels Test Strips. The system monitors key health indicators related to heart disease, diabetes and other chronic conditions. Test results are displayed in about two minutes. It can be programmed in one of six languages: English, Spanish, French, German, Italian, and Portuguese.

In 1998 the World Health Organization (WHO) was first to publish a definition for metabolic syndrome, however a definition currently receiving widespread acceptance is that published as part of the ATP III report (the third report of the National Cholesterol Education Program expert panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults).

ATP III defines metabolic syndrome as an individual exhibiting three or more of the following risk factors outlined on the following table:

Risk Factor